A. Brett Hauber
Senior Economist, Vice President of Health Preference Assessment
Brett Hauber, PhD, is an expert in health and environmental economics with more than 15 years of academic, research, and government experience. His primary area of specialization is conducting conjoint analyses and discrete-choice experiments to quantify preferences for medical interventions and health outcomes.
He also has extensive experience conducting benefit-risk analysis of patients and other health care decision makers. His most recent applied work has included discrete-choice experiments of patient and physician benefit-risk preferences for treatments for conditions in therapeutic areas such as neurology, infectious diseases, women's health, gastrointestinal diseases, diabetes, and oncology.
Dr. Hauber currently is the chair of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conjoint Analysis–Statistical Analysis, Reporting, and Conclusions (CA-SARC) task force and was previously a member of the ISPOR task force that developed the ISPOR Checklist for Good Research Practices in Conjoint Analysis.
Dr. Hauber's research has been published in numerous health outcomes and medical journals.
PhD, Economics, University of Delaware; MA, Economics, University of Delaware; BBA (summa cum laude), Temple University.
- Pharmaceutical Policy and Economics
- Health Economics
- June 24, 2014
First-of-its-kind textbook explores benefit-risk assessments in pharmaceuticals
– News Release